GIP and polycystic ovary syndrome: They demonstrated that increased levels of total gastric inhibitory polypeptide (GIP) and lower concentrations of late phase active glucagon-like peptide-1 (GLP-1) were common characteristics observed during the OGTT in women with PCOS, who had higher levels of C-peptide secretion in comparison to healthy controls.